| Hydroxyurea and Erythropoietin to Treat Sickle Cell Anemia (NCT00270478) | National Heart, Lung, and Blood Institute (NHLBI) | 2005-12-21 |
| Pharmacokinetic Study of ARALAST (Human Alpha1- PI) (NCT00242385) | Baxalta now part of Shire | 2005-12-20 |
| Phase I/II Thymus Transplantation With Immunosuppression #950 (NCT00579527) | Sumitomo Pharma Switzerland GmbH | 2005-12-19 |
| Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas (NCT00268385) | National Cancer Institute (NCI) | 2005-12-16 |
| A Dose-Escalation Study in Participants With Recurrent Malignant Glioma (NCT01682187) | Eli Lilly and Company | 2005-12-15 |
| Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma (NCT00295932) | Memorial Sloan Kettering Cancer Center | 2005-12-13 |
| Safety Study Using GSK233705 And Tiotropium In Patients With Chronic Obstructive Pulmonary Disease (NCT00279019) | GlaxoSmithKline | 2005-12-12 |
| Pilot Program for Targeted Prevention of Child or Adolescent Weight Gain (NCT00263536) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2005-12-05 |
| Safety and Immunogenicity Study of Group B Meningococcal Vaccine to Prevent Meningitis. (NCT00248833) | U.S. Army Medical Research and Development Command | 2005-12-05 |
| PET Imaging of Brain 5-HT(1A) Receptors Using [(11)C](-)-RWAY (NCT00263523) | National Institute of Mental Health (NIMH) | 2005-12-05 |
| STA-5326 Meslylate to Treat Gut Inflammation Associated With Common Variable Immunodeficiency (NCT00263237) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-12-02 |
| Sorafenib and Bortezomib in Treating Patients With Advanced Cancer (NCT00303797) | National Cancer Institute (NCI) | 2005-12-01 |
| Multiple Dose ASM8 in Mild Asthmatics (NCT00264966) | Syntara | 2005-12-01 |
| Restless Legs Syndrome Exercise Intervention (NCT00258492) | Northeastern Ohio Universities College of Medicine | 2005-12-01 |
| Erlotinib and Everolimus in Treating Patients With Metastatic Breast Cancer (NCT00574366) | Vanderbilt-Ingram Cancer Center | 2005-12-01 |
| PR-104 in Treating Patients With Advanced Solid Tumors (NCT00349167) | Proacta, Incorporated | 2005-12-01 |
| A Relative Bioavailability Study of Quinine Sulfate Capsules 324mg (NCT00726414) | Mutual Pharmaceutical Company, Inc. | 2005-12-01 |
| Observational Study Evaluating The Processing Or Breakdown Of GW679769 In Subjects With Hepatic Impairment (NCT00359177) | GlaxoSmithKline | 2005-12-01 |
| Multiple Dose Study of MPC-6827 in Subjects With Refractory Brain Metastases (NCT00393965) | Myrexis Inc. | 2005-12-01 |
| Dose Escalation Study of EM-1421 for the Treatment of Recurrent or Refractory Solid Tumors (NCT00259818) | Erimos Pharmaceuticals | 2005-12-01 |
| Drug Interaction Study Between Antimalarial and Anti-HIV Medications (NCT00266058) | University of California, San Francisco | 2005-12-01 |
| The Role of Peptide-loaded Dendritic Cells to Augment the Therapeutic Effect of Interleukin-2 (NCT00279058) | Hadassah Medical Organization | 2005-12-01 |
| Bioavailability Study of Desloratadine 5 mg Tablet of Dr. Reddy's Under Fed Conditions (NCT01314352) | Dr. Reddy's Laboratories Limited | 2005-12-01 |
| To Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 386 When Used in Combination With AMG 706, Bevacizumab, Sorafenib, or Sunitinib. (NCT00861419) | Amgen | 2005-12-01 |
| Pharmacokinetic of Tadalafil Co-administered With Tipranavir/Ritonavir to Healthy Male Volunteers (NCT02253862) | Boehringer Ingelheim | 2005-12-01 |
| Samarium 153 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT00316940) | Oncotherapeutics | 2005-12-01 |
| Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors (NCT00303940) | National Institutes of Health Clinical Center (CC) | 2005-12-01 |
| SJG-136 in Treating Patients With Relapsed or Refractory Acute Leukemia, Myelodysplastic Syndromes, Blastic Phase Chronic Myelogenous Leukemia, or Chronic Lymphocytic Leukemia (NCT00301769) | National Cancer Institute (NCI) | 2005-12-01 |
| A Study to Demonstrate the Bioequivalence of Sitagliptin/Metformin Combination Tablets and Concomitant Administration of Sitagliptin and Metformin as Individual Tablets (0431A-048) (NCT00961857) | Merck Sharp & Dohme LLC | 2005-12-01 |
| Phase Ia Dose-Escalation Safety, Pharmacodynamic and Pharmacokinetic Study of Imprime PGG™ Injection (NCT00542217) | HiberCell, Inc. | 2005-12-01 |
| Study to Assess the Clinical Efficacy and Safety of a Novel Method of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects by Epicutanous Allergen Administration (NCT00457444) | University of Zurich | 2005-12-01 |
| Phase I/II Study of 5-Azacytidine With Ara-C in Patients With Relapsed/Refractory Acute Myelogenous Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS) (NCT00569010) | M.D. Anderson Cancer Center | 2005-12-01 |
| The Effects of AZD2171 in Patients With Non-Small Cell Lung Cancer or Head & Neck Cancer (NCT00243347) | AstraZeneca | 2005-12-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Explorative Formulation of Insulin Degludec (NCT01865279) | Novo Nordisk A/S | 2005-12-01 |
| CP-868,596 And CP-868,596 Plus AG-013736 In Combination With Docetaxel In Advanced Solid Tumors (NCT00949624) | Arog Pharmaceuticals, Inc. | 2005-12-01 |
| N2004-04: Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma (NCT00295919) | New Approaches to Neuroblastoma Therapy Consortium | 2005-12-01 |
| A Study of the Pharmacokinetics and Immunologic Effects of Lipoic Acid in Multiple Sclerosis (NCT00676156) | Oregon Health and Science University | 2005-12-01 |
| Safety Study of IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) or Soft Tissue Sarcomas (STS) (NCT00276302) | Infinity Pharmaceuticals, Inc. | 2005-12-01 |
| 7-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic Syndromes (NCT00301938) | National Cancer Institute (NCI) | 2005-12-01 |
| Emergency Department Initiated Tobacco Treatment (EDITT) (NCT00252902) | National Institute on Drug Abuse (NIDA) | 2005-12-01 |
| Effects of Lidocaine Patch on Intradermal Capsaicin Induced Pain and Hyperalgesia (NCT00373893) | University of California, San Diego | 2005-12-01 |
| Temsirolimus in Treating Patients With Metastatic Solid Tumor or Lymphoma That Cannot Be Removed By Surgery Who Have Different Levels of Liver Function (NCT00275093) | National Cancer Institute (NCI) | 2005-12-01 |
| Lyophilized Black Raspberries in Adults With Familial Adenomatous Polyposis (FAP) (NCT00770991) | The Cleveland Clinic | 2005-12-01 |
| Evaluation of DHA for the Treatment of PSC (NCT00325013) | Beth Israel Deaconess Medical Center | 2005-12-01 |
| Pilot Study of Aspirin Versus Warfarin for Cervicocephalic Arterial Dissection (NCT00265408) | University of California, San Diego | 2005-12-01 |
| Testosterone-Driven Growth-Hormone (GH) Secretion in Aging Men (NCT00309855) | Mayo Clinic | 2005-12-01 |
| A Safety Study of Dapivirine (TMC120) Vaginal Microbicide Gel in Belgium (NCT00309205) | International Partnership for Microbicides, Inc. | 2005-12-01 |
| Use of Nesiritide (BNP) in Kidney Function in Patients With Congestive Heart Failure (CHF) and Kidney Failure (NCT00348556) | Horng Chen | 2005-12-01 |
| Study of Autologous Stem Cell Transplantation for Patients With Ischemic Stroke (NCT00473057) | Universidade Federal do Rio de Janeiro | 2005-12-01 |
| Study of BMS-663513 in Patients With Advanced Cancer (NCT00309023) | Bristol-Myers Squibb | 2005-12-01 |
| Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors (NCT00389922) | University of California, Davis | 2005-12-01 |
| Concurrent Pemetrexed, Cisplatin and Radiation Therapy in Patients With Stage IIIA/B Non Small Cell Lung Cancer (NCT00529100) | Eli Lilly and Company | 2005-12-01 |
| Bone Marrow Stem Cell Infusion Following a Heart Attack (NCT00268307) | Minneapolis Heart Institute Foundation | 2005-12-01 |
| Safety and Blood Level Study of Unit Dose Budesonide (NCT00627679) | Allergan | 2005-12-01 |
| Double Blind, Placebo-controlled, Study of the Safety, Tolerability and Pharmacokinetics of AIN457 in Rheumatoid Arthritis Patients (NCT00669942) | Novartis Pharmaceuticals | 2005-12-01 |
| Safety Study of Ranibizumab Eye Injections to Treat Choroidal Neovascularization That Was Caused Other Than by Age-Related Macular Degeneration. (NCT00395551) | Ophthalmic Consultants of Boston | 2005-12-01 |
| Safety, Immunological Effect and Efficacy of the Combined Application of MPL and Grass Pollen Allergen (NCT00241410) | Allergy Therapeutics | 2005-12-01 |
| Stem Cell Therapy for Vasculogenesis in Patients With Severe Myocardial Ischemia (NCT00260338) | Rigshospitalet, Denmark | 2005-12-01 |
| Fasting Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mg (NCT00649623) | Mylan Pharmaceuticals Inc | 2005-12-01 |
| Does Undercorrection of Myopia Retard Myopia Progression Among Kindergarten Children? (NCT00348166) | KK Women's and Children's Hospital | 2005-12-01 |
| CT-2103 in Combination With Gemcitabine in Metastatic Breast Cancer (NCT00270907) | M.D. Anderson Cancer Center | 2005-12-01 |
| External Beam Radiotherapy and Zevalin for Management of Indolent B-Cell Non-Hodgkin's Lymphoma (NCT00271050) | The Cleveland Clinic | 2005-12-01 |
| Fed Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mg (NCT00648219) | Mylan Pharmaceuticals Inc | 2005-12-01 |
| Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliation (NCT00264420) | The Cleveland Clinic | 2005-12-01 |
| Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid Tumor (NCT00454649) | Pfizer | 2005-12-01 |
| Treatment of Newly Diagnosed Brain Tumors With Chemotherapy and Radiation Using Cells Modified for Chemoprotection and an Experimental Drug to Decrease the Tumor Cell Resistance to Chemotherapy (NCT00272870) | Children's Hospital Medical Center, Cincinnati | 2005-12-01 |
| Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemic Study (NCT00978731) | Bristol-Myers Squibb | 2005-12-01 |
| Capecitabine, Docetaxel and Gemcitabine in Patients With Advanced Pancreas Cancer (NCT00320749) | Tony Bekaii-Saab | 2005-12-01 |
| Electrophysiological Effects of Tipranavir Co-administered With Ritonavir on the QT Interval in Healthy Female and Male Subjects (NCT02248883) | Boehringer Ingelheim | 2005-12-01 |
| Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma (NCT00112723) | National Cancer Institute (NCI) | 2005-12-01 |
| Amplifying Graft-Versus-Tumor Effect by Donor Regulatory T-Cell Depletion Before Donor Lymphocytes Infusion (NCT00987987) | Assistance Publique - Hôpitaux de Paris | 2005-12-01 |
| Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic Neoplasms (NCT00666926) | Verastem, Inc. | 2005-12-01 |
| Peritumoral Injection of Immature Dendritic Cells to Irradiated Skin Metastases of Solid Tumors (NCT00278018) | Hadassah Medical Organization | 2005-12-01 |
| Bioavailability Study of Dr. Reddy's Desloratadine Tablets, 5 mg Under Fasting Conditions. (NCT01314339) | Dr. Reddy's Laboratories Limited | 2005-12-01 |
| A Study of Single-Agent AT-101 in Men With Hormone Refractory Prostate Cancer (NCT00286806) | Ascenta Therapeutics | 2005-12-01 |
| Palifermin DDI (Drug Drug Interaction) (NCT00361348) | Swedish Orphan Biovitrum | 2005-12-01 |
| Rituximab Treatment to Block HLA Antibodies in Renal Transplant Recipients (NCT00261547) | Massachusetts General Hospital | 2005-12-01 |
| Inhaled Furosemide Versus Placebo for Acute Viral Bronchiolitis in Hospitalized Infants (NCT00261937) | Bnai Zion Medical Center | 2005-12-01 |
| Importance of Hand Washing After Each NAET® Treatment (NCT00292656) | Nambudripad's Allergy Research Foundation | 2005-12-01 |
| Autologous Bone Marrow Transplanted Via Transendocardial Catheter to Chronic Myocardial Infarct Border Zone (NCT00507468) | BioCardia, Inc. | 2005-12-01 |
| Clinical Trial of the Combination of Trastuzumab (Herceptin) and Tanespimycin in Patients With Solid Tumors and Her2 Positive Metastatic Breast Cancer That Have Previously Failed Herceptin (NCT00773344) | Bristol-Myers Squibb | 2005-12-01 |
| Evaluation of the Tantalus System in Type 2 Diabetic Subjects (NCT00276471) | MetaCure Limited | 2005-12-01 |
| Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck Cancer (NCT00176241) | Susanne Arnold | 2005-12-01 |
| Randomized, Double Blinded, Placebo Control Clinical Trial of Pandemic Influenza Inactive Vaccine on Healthy Subjects (NCT00356798) | Sinovac Biotech Co., Ltd | 2005-12-01 |
| A Phase I Study of G3139 Subcutaneous in Solid Tumors (NCT00543231) | Genta Incorporated | 2005-12-01 |
| Stanford Preschool Physical Activity Project (NCT00285792) | Stanford University | 2005-12-01 |
| Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By Surgery (NCT00293501) | University of Vermont | 2005-12-01 |
| Vaccine Therapy in Treating Patients With Stage III or Stage IV Breast Cancer (NCT00304096) | University of Virginia | 2005-12-01 |
| A Safety Study of RTA 744 in Patients With Recurrent High-Grade Gliomas (NCT00526812) | Biogen | 2005-11-30 |
| AZD2171 and Standard Combination Chemotherapy in Advanced Non-Small Cell Lung Cancer or Colorectal Cancer (NCT00343408) | NCIC Clinical Trials Group | 2005-11-29 |
| Safety Study of Larazotide Acetate to Treat Celiac Disease. (NCT00386165) | 9 Meters Biopharma, Inc. | 2005-11-29 |
| Radiofrequency Therapy-Induced Endogenous Heat-Shock Proteins With or Without Radiofrequency Ablation or Cryotherapy in Treating Patients With Stage IV Melanoma (NCT00568763) | Mayo Clinic | 2005-11-25 |
| Omalizumab to Treat Hyper-IgE (Job's) Syndrome (NCT00260702) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-11-24 |
| A First Time In Human Study To Assess The Compound GSK615915 (NCT00400660) | GlaxoSmithKline | 2005-11-23 |
| To Examine The Effects Of Lapatinib On Orally And Intravenously Administered Midazolam In Cancer Patients (NCT00258050) | GlaxoSmithKline | 2005-11-21 |
| GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma (NCT00293423) | University of California, San Francisco | 2005-11-18 |
| Safety Assessment of Two Schedules of Intravenous Infusions of SNS-595 for the Treatment of Hematologic Malignancies (NCT00246662) | Sunesis Pharmaceuticals | 2005-11-14 |
| MnSOD (Esophageal Protectant) to Prevent Esophagitis During Radiation/Chemotherapy Treatment for Non-Small Cell Lung Cancer (NSCLC) (NCT00618917) | Joel Greenberger | 2005-11-11 |
| Intratumoural Administration of Coxsackievirus A21 for the Control of Malignant Melanoma (PXS-X02) (NCT00235482) | Viralytics | 2005-11-08 |
| Clonidine for Relapse Prevention in Buprenorphine-Maintenance Patients (NCT00295308) | National Institute on Drug Abuse (NIDA) | 2005-11-08 |